GSK3B and psychiatric disorder: Despite these concerns, lithium salts, which include GSK3β as one of their targets (Stambolic et al., 1996), have been used for decades to treat psychiatric disorders (Freland and Beaulieu, 2012), demonstrating the feasibility of long-term GSK3β inhibition at appropriate doses.